Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Kolte-Patil completes second tranche payment of Rs. 70 crore for buy-out of ICICI Venture's 50% stake in Life Republic Township project in pune

Posted On: 2019-12-02 15:26:25

Kolte-Patil Developers Limited (BSE: 532924, NSE: KOILTEPATIL; KPDL), a leading Pune based real estate developer, announced that the company has completed the second tranche payment of Rs. 70 crore to India Advantage Fund-III (IAF-III) and India Advantage Fund-IV (IAF-IV) managed by ICICI Venture Funds Management Company Limited (ICICI Venture) for the buyout of their 50% stake in KPDL's flagship township project - Life Republic. As indicated earlier, the payment has been made largely funded through internal accruals. The current disbursement is as per schedule and follows the first installment of Rs. 70 crore paid out in March 2019. Following the buyout, KPDL'S economic interest in Life Republic will increase to 95% and the company's overall economic interest in its entire portfolio of projects will rise from [~60% to ~90%]. The Life Republic project resides in an SPV called Kolte-Patil I-Ven Townships (Pune) Ltd.

In May, 2019, Kolte-Patil had announced the buy-out of ICICI venture's stake for a cash consideration of Rs. 210 crore to be paid in three installments. The Company has already completed two installments and the last one is due in August 2020. In addition, 12 acres of land in Life Republic with FSI required to achieve saleable area equivalent to 1.4 million square feet, will be allocated to IAF III and IAF IV upon the project obtaining FSI of 1.0 from the present 0.5. Kolte-patil is funding the acquisition through internal accruals and bank borrowings. The company has strong visibility of cash flow from operations and maintains a healthy balance sheet position - as on September 30 2019, it had a net debt to equity ratio of 0.41 times.

Life Republic, being the company's flagship project spread across ~400 acres, is expected to continue to drive Kolte-Patil's revenue, profits, cash flows and return ratios in a significant manner over next decade-and-a-half. At present, ~4.2 million square feet has already been delivered in the project, making Life Republic an established destination for Pune home buyers and currently home to 10,000 residents. The project has 4 million square feet of pre-approved development space by MAHARERA, and is expected to add another 10,000 residents within three years. In FY19, sales of almost 0.9 million square feet were achieved at Life Republic and recent new launches/festive promotions continue to drive strong demand visibility among buyers. The total saleable area at Life republic is ~20 million square feet, based on FSI of 1.0, which is currently incorporated in the project design plans. However, the total FSI potential of the project is 1.7 based on the integrated township norms.

Commenting on this key development, Mr. Gopal Sarda, Group CEO, Kolte-Patil Developers Ltd. said, "Our decision to buy-out ICICI Ventures' stake in Life Republic is a key milestone in our growth journey and value creation program. The unique structuring of this buy-out makes it possible to maintain our asset light business model, by enabling tranche payments from internal accruals and also ensuring strong visibility of pre-sales, profit, cash flow and ROCE from the progressive monetization of this property across the next decade-and-a-half.

Life Republic, being our flagship integrated township project in Pune, has witnessed consistent demand from home buyers on the back of our 360-degree product offerings. Especially, in the last year and current year, the performance of the project has improved significantly. We have launched new offerings and promotions at this project and the customer traction at this project remains strong. The project is already a landmark destination in western Pune with best-in-class physical as well as social infrastructure. We believe that based on its strategic location and visibility of several infrastructure developments planned in the vicinity, the life cycle value of the project stands considerably enhanced."

A strong corporate governance framework along with the positive interplay of approvals, sales, collections and delivery, has strengthened our brand equity amongst our customers. The opportunity in residential real estate remains sizeable and we remain confident of improving of our growth trajectory further."

Shares of KOLTE-PATIL DEVELOPERS LTD. was last trading in BSE at Rs.235.55 as compared to the previous close of Rs. 235.45. The total number of shares traded during the day was 1803 in over 216 trades.

The stock hit an intraday high of Rs. 244 and intraday low of 235.25. The net turnover during the day was Rs. 432090.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Vanta Bioscience's facility gets NABL Accreditation

Karnataka Bank reports fraud by Hanung Toys and Textiles Ltd

HCL delivers powerful new value for 10 million Domino Applications Worldwide

Hindalco Industries Limited launches India's first All-Aluminium freight trailer

United Drilling Tools to get order from Halliburton Offshore Services Inc

Tata Power JV acquires 75.01% stake in Prayagraj Power Generation Company Ltd

Bharti Airtel Ltd proposes to raise $3 billion

Vaibhav Global Announces Completion of Buyback of its Equity Shares

SBI to divest its stake in UTI AMC through IPO

Lease agreement of Mount Shivalik Industries Ltd ends for running restaurant at Amer Fort

Artson Engineering Ltd receives order for Rs. 6.30 crores

India's largest kitchen appliance company TTK Prestige unveils 2020 plans

Shilpa Medicare gets EIR from US FDA for Raichur API unit

TCS Helps Ayala Land Digitally Transform its Finance Function

Ramco Systems FZ-LLC, Dubai secures 5 year order

Intellect Launches RM Office 2020 for Wealth Managers

GAIL awarded as the 'Project Management Company of the Year' 2019 by Hon'ble Minister of Petroleum & Natural Gas and Steel

Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection 3.5 mg/vial for Intravenous use only in the U.S. Market

L&T Construction bags new contracts for its various businesses

OnMobile collaborates with Samsung to build and manage its Contests ecosystem

Strides receives USFDA tentative approval for Diclofenac Potassium Softgel Capsules

CSB Bank Ltd reappoints MD & CEO

Vakrangee to launch India's First Rural Focussed Loyalty Program for its customers

Current Patent Laws are Inadequate for AI-related IP: New TCS Report

Caplin Steriles gets US FDA approval for Sodium Nitroprusside Injection

CARE reaffirms CP rating of Future Consumer Ltd

Eris Lifesciences Ltd announces acquisition of trademark- Zomelis together with its associated trademarks

Frontline Corporation Ltd commissions fuel pump as franchisee of Nayra Energy Ltd

NITCO Ltd Enters into Non-binding Term Sheet with Hines India Real Estate Pvt. Ltd.

OTS proposal of Sudal Industries Ltd Sanctioned

IRDAI approves True North's stake purchase in Max Bupa Health Insurance from Max India

ICRA revises ratings of IFCI Ltd

Offer for Sale of Shares by Promoters of HDFC Asset Management Company Ltd

NESTLE India Ltd board declares third interim dividend of Rs. 55

Steel Strips Wheels Ltd achieves total wheel rim sales of 12.52 lacs in November 2019

Wipro announces Advanced Cloud SOC Service Powered by Microsoft Azure Sentinel

Biocon Biologics Takes Forward Its Mission to Unlock Universal Access to Insulins Globally

HGS AxisPoint Health's Person-Centered Population Health Approach Receives Population Health Program Accreditation by NCQA

Paushak gets Responsible Care logo

NATCO Pharma Ltd completes investment in OMRV Hospitals Pvt Ltd

Lupin Foundation Wins Award for Excellence in Corporate Social Responsibility at India Pharma Awards 2019

Ultracab (India) Ltd receives order from MSEDCL for Rs. 23.69 crore

New Study by TCS: German Companies Have Sharply Hiked Spending on Digital Transformation

Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets

Siddharth Mittal Takes Over as CEO and Joint Managing Director of Biocon Limited

Maruti Suzuki India Ltd to increase price of vehicles from January 2020

Lupin Wins Award for Operational Excellence in Manufacturing at India Pharma Awards 2019

Thomas Cook India signs an agreement to acquire the rights to the Thomas Cook Brand for the India, Sri Lanka & Mauritius markets

Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.

Tata Motors bags orders to supply over 2300 buses to various State Transport Undertakings







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019